Catalyst Wire Dossier Catalyst Wire Dossier

DHT-Gel

· ASCEND Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DHT-Gel, covering 2022-08-15 to 2022-08-15. Get the full timeline:

Most recent: Clinical Trial Update: Study of DHT-Gel to Treat the Symptoms of Low Testosterone in Men 55-80 [Phase 2]

See pricing